Bortezomib induction, consolidation and maintenance therapy in patients with newly diagnosed multiple myeloma
Latest Information Update: 28 Jan 2019
At a glance
- Drugs Bortezomib (Primary) ; Autologous stem cell therapy; Cyclophosphamide; Cyclophosphamide; Dexamethasone; Melphalan
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms KHSG MM13
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
- 28 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Jun 2013 New trial record